Skip to content
Tallac Therapeutics, Inc
Tallac Therapeutics, Inc

News

Home
News
Latest News

Latest News

In Latest NewsPosted April 12, 2021

Tallac AACR 2021 Presentation

More
In Latest NewsPosted March 12, 2021

AACR 2021 presentation on preclinical data for TAC-001

More
In Latest NewsPosted March 4, 2021

ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics

More
In Latest NewsPosted December 1, 2020

Tallac Therapeutics Launches with $62 Million in Series A Financing to Advance Novel Immunotherapies for Cancer

More
In Latest NewsPosted November 5, 2020

SITC 2020 Presentation

More

Categories

  • Latest News (5)

Recent Posts

  • Tallac AACR 2021 Presentation
  • AACR 2021 presentation on preclinical data for TAC-001
  • ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics
  • Tallac Therapeutics Launches with $62 Million in Series A Financing to Advance Novel Immunotherapies for Cancer
  • SITC 2020 Presentation

Archives

  • April 2021
  • March 2021
  • December 2020
  • November 2020
Tallac Therapeutics, Inc
  • (650) 866-1966
866 Malcolm Road Suite 100, Burlingame, CA 94010
Linkedin-in
Envelope

Copyright © 2020 Tallac Therapeutics, Inc. All Rights Reserved.